by Jennifer O'Reilly Mott | Apr 30, 2026 | Press Releases
The most intense distrust is softening. The breadth of skepticism has not changed. PENSACOLA, Fla., April 23, 2026: Bionews today released the Q1 2026 Rare Trust in AI Index, the second quarterly wave of its proprietary index tracking how rare disease patients...
by Jennifer O'Reilly Mott | Mar 2, 2026 | Press Releases
A survey of 311 people living with MG finds that three emotions explain 63% of all variation in mental health outcomes, challenging how we think about rare disease care PENSACOLA, Fla., Mar. 2, 2026 — New research published by Bionews, Inc. is changing the...
by Bionews Staff | Dec 9, 2025 | Press Releases
With an initial index score of –0.87, the report highlights both the trust gap and the emerging opportunities for AI to support patients more effectively. PENSACOLA, Fla., Dec. 10, 2025 — Bionews, a leading rare disease news and community network, today announced the...
by Bionews Staff | May 7, 2025 | Press Releases
Bionews wrapped up an energizing week at the World Orphan Drug Congress 2025 in Boston, where we had the opportunity to share the evolution of how we engage rare disease communities online. The presentation, led by Marcella Debidda, PhD, and Ethan Ash, senior VP of...
by Bionews Staff | Mar 21, 2025 | Press Releases
Bionews is excited to announce our participation in the World Orphan Drug Congress 2025. This year’s presentation delves into innovative strategies to engage rare disease patients online by exploring practical approaches to reaching these communities, delivering...
by Jennifer Powell | Aug 19, 2024 | Press Releases
PENSACOLA, Florida – August 19, 2024 — For millions of people living with rare diseases, every day can bring challenges with isolation and uncertainty. Bionews, a leading digital health solutions company dedicated to empowering the rare disease community, is proud...
